{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:12:05Z","timestamp":1790172725959,"version":"4.1.0"},"reference-count":330,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Sandler Family Foundation"},{"DOI":"10.13039\/100006732","name":"NYU","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003965","name":"Migraine Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003965","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Merck and Co"},{"DOI":"10.13039\/100009360","name":"King\u2019s College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009360","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FP7 project EUROHEADPAIN","award":["602633"],"award-info":[{"award-number":["602633"]}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/P006264\/1"],"award-info":[{"award-number":["MR\/P006264\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000283","name":"Migraine Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000283","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.pharmthera.2016.12.005","type":"journal-article","created":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T15:47:47Z","timestamp":1480693667000},"page":"151-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Current and novel insights into the neurophysiology of migraine and its implications for therapeutics"],"prefix":"10.1016","volume":"172","author":[{"given":"Simon","family":"Akerman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Romero-Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip R.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2016.12.005_bb0005","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1001\/archneur.62.8.1270","article-title":"A positron emission tomographic study in spontaneous migraine","volume":"62","author":"Afridi","year":"2005","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0010","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1212\/WNL.0b013e3182824e66","article-title":"A randomized controlled trial of intranasal ketamine in migraine with prolonged aura","volume":"80","author":"Afridi","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0015","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/brain\/awh416","article-title":"A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate","volume":"128","author":"Afridi","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0020","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pain.2006.01.016","article-title":"Greater occipital nerve injection in primary headache syndromes - Prolonged effects from a single injection","volume":"122","author":"Afridi","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0025","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/01.wnr.0000175250.33159.a9","article-title":"Topiramate inhibits cortical spreading depression in rat and cat: Impact in migraine aura","volume":"16","author":"Akerman","year":"2005","journal-title":"Neuroreport"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0030","doi-asserted-by":"crossref","first-page":"308ra157","DOI":"10.1126\/scitranslmed.aaa7557","article-title":"Neuronal PAC1 receptors mediate delayed activation and sensitization of trigeminocervical neurons: Relevance to migraine","volume":"7","author":"Akerman","year":"2015","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0035","first-page":"211","article-title":"A translational approach to studying triptan-induced reversal of established central sensitization of trigeminovascular neurons","volume":"33","author":"Akerman","year":"2013","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0040","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nrn3057","article-title":"Diencephalic and brainstem mechanisms in migraine","volume":"12","author":"Akerman","year":"2011","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0045","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1526-4610.2009.01501.x","article-title":"Oxygen inhibits neuronal activation in the trigeminocervical complex after stimulation of trigeminal autonomic reflex, but not during direct dural activation of trigeminal afferents","volume":"49","author":"Akerman","year":"2009","journal-title":"Headache"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0050","doi-asserted-by":"crossref","first-page":"14869","DOI":"10.1523\/JNEUROSCI.0943-13.2013","article-title":"Endocannabinoids in the brainstem modulate dural trigeminovascular nociceptive traffic via CB1 and \u201ctriptan\u201d receptors: Implications in migraine","volume":"33","author":"Akerman","year":"2013","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0055","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1093\/brain\/aws249","article-title":"A translational in vivo model of trigeminal autonomic cephalalgias: Therapeutic characterization","volume":"135","author":"Akerman","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0060","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S1474-4422(13)70067-X","article-title":"Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: A cross-sectional study","volume":"12","author":"Amin","year":"2013","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0065","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/brain\/awt369","article-title":"Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38","volume":"137","author":"Amin","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0070","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.pain.2012.01.005","article-title":"mRNA expression of 5-hydroxytryptamine 1B, 1D, and 1F receptors and their role in controlling the release of calcitonin gene-related peptide in the rat trigeminovascular system","volume":"153","author":"Amrutkar","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0075","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1177\/0333102411418259","article-title":"Topiramate in the treatment of migraine: A kainate (glutamate) receptor antagonist within the trigeminothalamic pathway","volume":"31","author":"Andreou","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0080","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1093\/brain\/aww118","article-title":"Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in migraine","volume":"139","author":"Andreou","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0085","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.nbd.2009.10.007","article-title":"GABA and valproate modulate trigeminovascular nociceptive transmission in the thalamus","volume":"37","author":"Andreou","year":"2010","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0090","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/j.1526-4610.2010.01661.x","article-title":"Electrical stimulation of sphenopalatine ganglion for acute treatment of cluster headaches","volume":"50","author":"Ansarinia","year":"2010","journal-title":"Headache"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0095","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1177\/0333102411399349","article-title":"Cathodal transcranial direct current stimulation of the visual cortex in the prophylactic treatment of migraine","volume":"31","author":"Antal","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0100","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1177\/0333102412451360","article-title":"Prostaglandin E2 induces immediate migraine-like attack in migraine patients without aura","volume":"32","author":"Antonova","year":"2012","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0105","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0167-0115(92)90621-Z","article-title":"Pituitary adenylate cyclase activating polypeptide (PACAP): Discovery and current status of research","volume":"37","author":"Arimura","year":"1992","journal-title":"Regulatory Peptides"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0110","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1212\/WNL.0b013e3181f9626a","article-title":"Dilation by CGRP of middle meningeal artery and reversal by sumatriptan in normal volunteers","volume":"75","author":"Asghar","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0115","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1046\/j.1468-2982.1999.019008708.x","article-title":"The cortical silent period is shortened in migraine with aura","volume":"19","author":"Aurora","year":"1999","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0120","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.1526-4610.1999.3907469.x","article-title":"The occipital cortex is hyperexcitable in migraine: Experimental evidence","volume":"39","author":"Aurora","year":"1999","journal-title":"Headache"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0125","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1152\/physrev.00027.2014","article-title":"Spreading depression, spreading depolarizations, and the cerebral vasculature","volume":"95","author":"Ayata","year":"2015","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0130","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/ana.20778","article-title":"Suppression of cortical spreading depression in migraine prophylaxis","volume":"59","author":"Ayata","year":"2006","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0135","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(00)04250-1","article-title":"Brainstem activation specific to migraine headache","volume":"357","author":"Bahra","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0140","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S0022-3565(25)39457-7","article-title":"Passage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood-brain barrier","volume":"267","author":"Banks","year":"1993","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0145","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1093\/brain\/awf166","article-title":"Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input","volume":"125","author":"Bartsch","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0150","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/brain\/awg190","article-title":"Increased responses in trigeminocervical nociceptive neurons to cervical input after stimulation of the dura mater","volume":"126","author":"Bartsch","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0155","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1743-5013.2005.20201.x","article-title":"Anatomy and physiology of pain referral in primary and cervicogenic headache disorders","volume":"2","author":"Bartsch","year":"2005","journal-title":"Headache Currents"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0160","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ana.20193","article-title":"Activation of 5-HT(1B\/1D) receptor in the periaqueductal gray inhibits nociception","volume":"56","author":"Bartsch","year":"2004","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0165","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.pain.2004.02.005","article-title":"Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area","volume":"109","author":"Bartsch","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0170","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pain.2005.05.015","article-title":"Inhibition of nociceptive dural input in the trigeminal nucleus caudalis by somatostatin receptor blockade in the posterior hypothalamus","volume":"117","author":"Bartsch","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0175","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.nbd.2004.03.015","article-title":"Hypothalamic activation after stimulation of the superior sagittal sinus in the cat: A Fos study","volume":"16","author":"Benjamin","year":"2004","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0180","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1186\/s10194-015-0535-3","article-title":"Single-pulse transcranial magnetic stimulation (sTMS) for the acute treatment of migraine: Evaluation of outcome data for the UK post market pilot program","volume":"16","author":"Bhola","year":"2015","journal-title":"The Journal of Headache and Pain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0185","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S1474-4422(15)00249-5","article-title":"Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study","volume":"14","author":"Bigal","year":"2015","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0190","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(15)00245-8","article-title":"Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: A multicentre, randomised, double-blind, placebo-controlled, phase 2b study","volume":"14","author":"Bigal","year":"2015","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0195","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/0333102413517775","article-title":"Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program","volume":"34","author":"Bigal","year":"2013","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0200","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1177\/0333102414527646","article-title":"Cardiovascular and hemodynamic parameters in women following prolonged CGRP inhibition using LBR-101, a monoclonal antibody against CGRP","volume":"34","author":"Bigal","year":"2014","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0205","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.nbd.2010.10.014","article-title":"Migraine preventive drugs differentially affect cortical spreading depression in rat","volume":"41","author":"Bogdanov","year":"2011","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0210","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nm0202-136","article-title":"Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model","volume":"8","author":"Bolay","year":"2002","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0215","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1468-2982.2008.01807.x","article-title":"The in vivo effect of VIP, PACAP-38 and PACAP-27 and mRNA expression of their receptors in rat middle meningeal artery","volume":"29","author":"Boni","year":"2009","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0220","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/sj.bjp.0703081","article-title":"No contractile effect for 5-HT1D and 5-HT1F receptor agonists in human and bovine cerebral arteries: similarity with human coronary artery","volume":"129","author":"Bouchelet","year":"2000","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0225","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0026-895X(25)09209-0","article-title":"Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels","volume":"50","author":"Bouchelet","year":"1996","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0230","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/jnnp.2009.190223","article-title":"Photophobia in migraine: An interictal PET study of cortical hyperexcitability and its modulation by pain","volume":"81","author":"Boulloche","year":"2010","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0235","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0028-3908(94)90067-1","article-title":"Localization of 5-HT1B, 5-HT1D alpha, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain","volume":"33","author":"Bruinvels","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0240","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ana.10785","article-title":"Analgesic triptan action in an animal model of intracranial pain: A race against the development of central sensitization","volume":"55","author":"Burstein","year":"2004","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0245","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/cne.20688","article-title":"Unitary hypothesis for multiple triggers of the pain and strain of migraine","volume":"493","author":"Burstein","year":"2005","journal-title":"The Journal of Comparative Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0250","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1523\/JNEUROSCI.07-12-04159.1987","article-title":"Direct somatosensory projections from the spinal cord to the hypothalamus and telencephalon","volume":"7","author":"Burstein","year":"1987","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0255","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ana.10786","article-title":"Defeating migraine pain with triptans: A race against the development of cutaneous allodynia","volume":"55","author":"Burstein","year":"2004","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0260","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/brain\/123.8.1703","article-title":"The development of cutaneous allodynia during a migraine attack","volume":"123","author":"Burstein","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0265","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0006-8993(90)90179-F","article-title":"The cells of origin of the spinothalamic tract of the rat: A quantitative reexamination","volume":"511","author":"Burstein","year":"1990","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0270","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ana.21994","article-title":"Thalamic sensitization transforms localized pain into widespread allodynia","volume":"68","author":"Burstein","year":"2010","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0275","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0035-3787(05)85109-4","article-title":"Effects of sensitization of trigeminovascular neurons to triptan therapy during migraine","volume":"161","author":"Burstein","year":"2005","journal-title":"Revue Neurologique (Paris)"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0280","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1523\/JNEUROSCI.0373-15.2015","article-title":"Migraine: multiple processes, complex pathophysiology","volume":"35","author":"Burstein","year":"2015","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0285","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1152\/jn.1998.79.2.964","article-title":"Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons","volume":"79","author":"Burstein","year":"1998","journal-title":"Journal of Neurophysiology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0290","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1476-5381.1990.tb14679.x","article-title":"The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater","volume":"99","author":"Buzzi","year":"1990","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0295","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1468-2982.1991.1104165.x","article-title":"Evidence for 5-HT1B\/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine","volume":"11","author":"Buzzi","year":"1991","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0300","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/head.12458","article-title":"A double-blind, placebo-controlled study of repetitive transnasal sphenopalatine ganglion blockade with tx360((R)) as acute treatment for chronic migraine","volume":"55","author":"Cady","year":"2015","journal-title":"Headache"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0305","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/0333102414544979","article-title":"Randomized controlled trial of the orexin receptor antagonist filorexant for migraine prophylaxis","volume":"35","author":"Chabi","year":"2015","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0310","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s40265-014-0262-0","article-title":"Glutamate receptor antagonists in the management of migraine","volume":"74","author":"Chan","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0315","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/0333102410375624","article-title":"Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery","volume":"31","author":"Chan","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0320","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.pain.2011.07.002","article-title":"Trigeminocervical complex responses after lesioning dopaminergic A11 nucleus are modified by dopamine and serotonin mechanisms","volume":"152","author":"Charbit","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0325","doi-asserted-by":"crossref","first-page":"12532","DOI":"10.1523\/JNEUROSCI.2887-09.2009","article-title":"Neurons of the dopaminergic\/calcitonin gene-related peptide A11 cell group modulate neuronal firing in the trigeminocervical complex: An electrophysiological and immunohistochemical study","volume":"29","author":"Charbit","year":"2009","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0330","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nrneurol.2013.192","article-title":"Cortical spreading depression and migraine","volume":"9","author":"Charles","year":"2013","journal-title":"Nature Reviews. Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0335","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s10194-007-0406-7","article-title":"Memantine for prevention of migraine: A retrospective study of 60 cases","volume":"8","author":"Charles","year":"2007","journal-title":"The Journal of Headache and Pain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0340","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/j.pain.0000000000000437","article-title":"Vagus nerve stimulation inhibits cortical spreading depression","volume":"157","author":"Chen","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0345","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/0333102415610874","article-title":"The influence of genetic constitution on migraine drug responses","volume":"36","author":"Christensen","year":"2016","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0350","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/ner.12400","article-title":"Long-term pain reduction does not imply improved functional outcome in patients treated with combined supraorbital and occipital nerve stimulation for chronic migraine","volume":"19","author":"Clark","year":"2016","journal-title":"Neuromodulation"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0355","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.brainres.2010.09.004","article-title":"Distribution of 5-HT(1B), 5-HT(1D) and 5-HT(1F) receptor expression in rat trigeminal and dorsal root ganglia neurons: relevance to the selective anti-migraine effect of triptans","volume":"1361","author":"Classey","year":"2010","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0360","first-page":"229","article-title":"Thalamo-cortical network changes during the migraine cycle: Insights from MRI-based microstructural and functional resting-state network correlation analysis","volume":"35","author":"Coppola","year":"2015","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0365","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1468-2982.2007.01500.x","article-title":"Is the cerebral cortex hyperexcitable or hyperresponsive in migraine?","volume":"27","author":"Coppola","year":"2007","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0370","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neuroscience.2011.10.055","article-title":"Distribution of vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, nitric oxide synthase, and their receptors in human and rat sphenopalatine ganglion","volume":"202","author":"Csati","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0375","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-2999(97)83024-5","article-title":"Rizatriptan has central antinociceptive effects against durally evoked responses","volume":"328","author":"Cumberbatch","year":"1997","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0380","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0014-2999(98)00764-X","article-title":"The effects of 5-HT1A, 5-HT1B and 5-HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats","volume":"362","author":"Cumberbatch","year":"1998","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0385","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0006-8993(78)91039-9","article-title":"The diurnal variations of dopamine-beta-hydroxylase activity in the hypothalamus and locus coeruleus of the rat","volume":"155","author":"Daiguji","year":"1978","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0390","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0006-8993(88)90806-2","article-title":"Properties of feline thalamic neurons activated by stimulation of the middle meningeal artery and sagittal sinus","volume":"454","author":"Davis","year":"1988","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0395","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1152\/jn.1988.59.2.648","article-title":"Responses of feline trigeminal spinal tract nucleus neurons to stimulation of the middle meningeal artery and sagittal sinus","volume":"59","author":"Davis","year":"1988","journal-title":"Journal of Neurophysiology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0400","first-page":"247","article-title":"Safety, pharmacokinetics, and pharmacodynamics of ly2951742: A monoclonal antibody targeting CGRP","volume":"33","author":"de Hoon","year":"2013","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0405","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0410","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/j.1526-4610.2007.00776.x","article-title":"Hypothalamic activation in spontaneous migraine attacks","volume":"47","author":"Denuelle","year":"2007","journal-title":"Headache"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0415","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3109\/00207454.2011.605191","article-title":"The impact of allodynia on the efficacy of almotriptan when given early in migraine: Data from the \u201cact when mild\u201d study","volume":"121","author":"Diaz-Insa","year":"2011","journal-title":"The International Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0420","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1177\/0333102410388435","article-title":"BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study","volume":"31","author":"Diener","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0425","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S1474-4422(15)00198-2","article-title":"New therapeutic approaches for the prevention and treatment of migraine","volume":"14","author":"Diener","year":"2015","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0430","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S1474-4422(14)70209-1","article-title":"Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: A randomised, double-blind, placebo-controlled, exploratory phase 2 trial","volume":"13","author":"Dodick","year":"2014","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0435","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S1474-4422(14)70128-0","article-title":"Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: A phase 2, randomised, double-blind, placebo-controlled study","volume":"13","author":"Dodick","year":"2014","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0440","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/0333102414543331","article-title":"Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: Long-term results from a randomized, multicenter, double-blinded, controlled study","volume":"35","author":"Dodick","year":"2015","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0445","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/sj.bjp.0703110","article-title":"Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist","volume":"129","author":"Doods","year":"2000","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0450","first-page":"357","article-title":"Efficacy and tolerability of the neurogenic inflammation inhibitor, 4991W93 in the acute treatment of migraine","volume":"19","author":"Earl","year":"1999","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0455","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0306-4522(98)00366-2","article-title":"Release of substance P, calcitonin gene-related peptide and prostaglandin E2 from rat dura mater encephali following electrical and chemical stimulation in vitro","volume":"89","author":"Ebersberger","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0460","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/ana.21537","article-title":"Medullary pain facilitating neurons mediate allodynia in headache-related pain","volume":"65","author":"Edelmayer","year":"2009","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0465","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0167-0115(88)90075-4","article-title":"Neurokinin A in cerebral vessels: Characterization, localization and effects in vitro","volume":"20","author":"Edvinsson","year":"1988","journal-title":"Regulatory Peptides"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0470","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0165-1838(98)00033-2","article-title":"Calcitonin gene-related peptide and nitric oxide in the trigeminal ganglion: cerebral vasodilatation from trigeminal nerve stimulation involves mainly calcitonin gene-related peptide","volume":"70","author":"Edvinsson","year":"1998","journal-title":"Journal of the Autonomic Nervous System"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0475","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.neuroscience.2010.05.016","article-title":"Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion","volume":"169","author":"Eftekhari","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0480","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.brainres.2014.11.031","article-title":"Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier","volume":"1600","author":"Eftekhari","year":"2015","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0485","first-page":"94","article-title":"Brain stem reflexes: Probing human trigeminal nociception","volume":"15","author":"Ellrich","year":"2000","journal-title":"News in Physiological Sciences"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0490","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0304-3959(00)00405-X","article-title":"Modulation of neuronal activity in the nucleus raphe magnus by the 5-HT(1)-receptor agonist naratriptan in rat","volume":"90","author":"Ellrich","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0495","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1474-4422(12)70047-9","article-title":"Efficacy and tolerability of lasmiditan, an oral 5-HT(1F) receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study","volume":"11","author":"Farkkila","year":"2012","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0500","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJM199108013250504","article-title":"Treatment of migraine attacks with sumatriptan. The Subcutaneous Sumatriptan International Study Group","volume":"325","author":"Ferrari","year":"1991","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0505","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1177\/0333102410375512","article-title":"Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan--A randomised proof-of-concept trial","volume":"30","author":"Ferrari","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0510","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1474-4422(14)70220-0","article-title":"Migraine pathophysiology: Lessons from mouse models and human genetics","volume":"14","author":"Ferrari","year":"2015","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0515","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrn1431","article-title":"State-dependent opioid control of pain","volume":"5","author":"Fields","year":"2004","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0520","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1098\/rstb.1985.0037","article-title":"Anatomy and physiology of a nociceptive modulatory system","volume":"308","author":"Fields","year":"1985","journal-title":"Philosophical Transactions of the Royal Society London B Biological Sciences"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0525","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0006-8993(77)90596-0","article-title":"Nucleus raphe magnus inhibition of spinal cord dorsal horn neurons","volume":"126","author":"Fields","year":"1977","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0530","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1523\/JNEUROSCI.03-12-02545.1983","article-title":"The activity of neurons in the rostral medulla of the rat during withdrawal from noxious heat","volume":"3","author":"Fields","year":"1983","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0535","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev.ne.14.030191.001251","article-title":"Neurotransmitters in nociceptive modulatory circuits","volume":"14","author":"Fields","year":"1991","journal-title":"Annual Review of Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0540","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/306684a0","article-title":"Evidence that disinhibition of brain stem neurones contributes to morphine analgesia","volume":"306","author":"Fields","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0545","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.1523\/JNEUROSCI.0869-05.2005","article-title":"The nonpeptide calcitonin gene-related peptide receptor antagonist BIBN4096BS lowers the activity of neurons with meningeal input in the rat spinal trigeminal nucleus","volume":"25","author":"Fischer","year":"2005","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0550","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1526-4610.2005.05136.x","article-title":"The association of brainstem lesions with migraine-like headache: An imaging study of multiple sclerosis","volume":"45","author":"Gee","year":"2005","journal-title":"Headache"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0555","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1212\/WNL.0000000000002789","article-title":"The migraine postdrome: An electronic diary study","volume":"87","author":"Giffin","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0560","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1212\/01.WNL.0000052998.58526.A9","article-title":"Premonitory symptoms in migraine: An electronic diary study","volume":"60","author":"Giffin","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0565","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013","volume":"386","author":"Global Burden of Disease Study C","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0570","first-page":"R517","article-title":"Effect of stimulation of the facial nerve on regional cerebral blood flow and glucose utilization in cats","volume":"257","author":"Goadsby","year":"1989","journal-title":"American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0575","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0006-8993(90)91211-X","article-title":"Sphenopalatine ganglion stimulation increases regional cerebral blood flow independent of glucose utilization in the cat","volume":"506","author":"Goadsby","year":"1990","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0580","first-page":"R255","article-title":"Characteristics of facial nerve elicited cerebral vasodilatation determined with laser Doppler flowmetry","volume":"260","author":"Goadsby","year":"1991","journal-title":"American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0585","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1474-4422(02)00104-7","article-title":"Pathophysiology of cluster headache: A trigeminal autonomic cephalgia","volume":"1","author":"Goadsby","year":"2002","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0590","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0006-8993(00)02630-5","article-title":"Glutamatergic transmission in the trigeminal nucleus assessed with local blood flow","volume":"875","author":"Goadsby","year":"2000","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0595","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0306-4522(03)00570-0","article-title":"Evidence for serotonin (5-HT)1B, 5-HT1D and 5-HT1F receptor inhibitory effects on trigeminal neurons with craniovascular input","volume":"122","author":"Goadsby","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0600","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ana.410330109","article-title":"The trigeminovascular system and migraine: Studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats","volume":"33","author":"Goadsby","year":"1993","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0605","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0304-3959(96)03118-1","article-title":"Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B\/D receptor agonist zolmitriptan (311C90): Are brain stem sites therapeutic target in migraine?","volume":"67","author":"Goadsby","year":"1996","journal-title":"Pain"},{"issue":"Pt 3","key":"10.1016\/j.pharmthera.2016.12.005_bb0610","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1469-7580.1997.19030367.x","article-title":"The distribution of trigeminovascular afferents in the nonhuman primate brain Macaca nemestrina: A c-fos immunocytochemical study","volume":"190","author":"Goadsby","year":"1997","journal-title":"Journal of Anatomy"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0615","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/ana.410430605","article-title":"Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT1B\/1D receptor: A central action in migraine?","volume":"43","author":"Goadsby","year":"1998","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0620","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0304-3959(99)00025-1","article-title":"Differential effects of low dose CP122,288 and eletriptan on Fos expression due to stimulation of the superior sagittal sinus in cat","volume":"82","author":"Goadsby","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0625","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1468-2982.1997.1703153.x","article-title":"Direct evidence for central sites of action of zolmitriptan (311C90): An autoradiographic study in cat [see comments]","volume":"17","author":"Goadsby","year":"1997","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0630","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/sj.bjp.0701456","article-title":"Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT(1B\/1D)) receptors","volume":"122","author":"Goadsby","year":"1997","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0635","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/ana.10066","article-title":"Evidence for postjunctional serotonin (5-HT1) receptors in the trigeminocervical complex","volume":"50","author":"Goadsby","year":"2001","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0640","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.neuroscience.2009.03.019","article-title":"Neurobiology of migraine","volume":"161","author":"Goadsby","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0645","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1055\/s-0030-1249227","article-title":"Trigeminal autonomic cephalalgias: Paroxysmal hemicrania, SUNCT\/SUNA and hemicrania continua","volume":"30","author":"Goadsby","year":"2010","journal-title":"Seminars in Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0650","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ana.410280213","article-title":"Vasoactive peptide release in the extracerebral circulation of humans during migraine headache","volume":"28","author":"Goadsby","year":"1990","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0655","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0165-1838(84)90053-5","article-title":"The peripheral pathway for extracranial vasodilatation in the cat","volume":"10","author":"Goadsby","year":"1984","journal-title":"Journal of the Autonomic Nervous System"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0660","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1468-2982.2008.01546.x","article-title":"Early vs. non-early intervention in acute migraine-\u2018Act when Mild (AwM)\u2019. A double-blind, placebo-controlled trial of almotriptan","volume":"28","author":"Goadsby","year":"2008","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0665","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1046\/j.1468-2982.2001.00161.x","article-title":"Lanepitant, an NK-1 antagonist, in migraine prevention","volume":"21","author":"Goldstein","year":"2001","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0670","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1046\/j.1468-2982.1997.1707785.x","article-title":"Ineffectiveness of neurokinin-1 antagonist in acute migraine: A crossover study","volume":"17","author":"Goldstein","year":"1997","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0675","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/B978-0-444-59489-1.00010-0","article-title":"Orexin receptors as therapeutic drug targets","volume":"198","author":"Gotter","year":"2012","journal-title":"Progress in Brain Research"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0680","series-title":"Anatomy of the Human Body","author":"Gray","year":"1918"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0685","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1476-5381.2012.01871.x","article-title":"Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1","volume":"166","author":"Harmar","year":"2012","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0690","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1474-4422(09)70135-8","article-title":"Effects of tonabersat on migraine with aura: A randomised, double-blind, placebo-controlled crossover study","volume":"8","author":"Hauge","year":"2009","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0695","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/0333102413485658","article-title":"The International Classification of Headache Disorders, 3rd edition (beta version)","volume":"33","author":"Headache Classification Committee of the International Headache Society","year":"2013","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0700","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1212\/WNL.0b013e31827688ee","article-title":"Orexin receptor antagonism for treatment of insomnia: A randomized clinical trial of suvorexant","volume":"79","author":"Herring","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0705","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1177\/0333102411398399","article-title":"Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine","volume":"31","author":"Hewitt","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0710","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1212\/01.WNL.0000286940.29755.61","article-title":"Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine","volume":"70","author":"Ho","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0715","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.nbd.2014.10.022","article-title":"Evidence for orexinergic mechanisms in migraine","volume":"74","author":"Hoffmann","year":"2015","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0720","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1177\/0333102410370875","article-title":"Lack of efficacy of the selective iNOS inhibitor GW274150 in prophylaxis of migraine headache","volume":"30","author":"Hoivik","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0725","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1177\/0333102414541687","article-title":"Headache and sleep: Shared pathophysiological mechanisms","volume":"34","author":"Holland","year":"2014","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0730","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1526-4610.2007.00842.x","article-title":"The hypothalamic orexinergic system: pain and primary headaches","volume":"47","author":"Holland","year":"2007","journal-title":"Headache"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0735","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1124\/jpet.105.090951","article-title":"Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception","volume":"315","author":"Holland","year":"2005","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0740","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1111\/j.1460-9568.2006.05168.x","article-title":"Modulation of nociceptive dural input to the trigeminal nucleus caudalis via activation of the orexin 1 receptor in the rat","volume":"24","author":"Holland","year":"2006","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0745","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1469-7580.2001.19810029.x","article-title":"Fos expression in the midbrain periaqueductal grey after trigeminovascular stimulation","volume":"198","author":"Hoskin","year":"2001","journal-title":"Journal of Anatomy"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0750","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/brain\/119.5.1419","article-title":"Sumatriptan can inhibit trigeminal afferents by an exclusively neural mechanism","volume":"119","author":"Hoskin","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0755","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1046\/j.1469-7580.1999.19440579.x","article-title":"Stimulation of the middle meningeal artery leads to Fos expression in the trigeminocervical nucleus: A comparative study of monkey and cat","volume":"194","author":"Hoskin","year":"1999","journal-title":"Journal of Anatomy"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0760","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0006-8993(83)90664-9","article-title":"A direct hypothalamic projection to the superior salivatory nucleus neurons in the rat. A study using anterograde autoradiographic and retrograde HRP methods","volume":"266","author":"Hosoya","year":"1983","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0765","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/BF00228793","article-title":"Descending projections from the hypothalamic paraventricular nucleus to the A5 area, including the superior salivatory nucleus, in the rat","volume":"82","author":"Hosoya","year":"1990","journal-title":"Experimental Brain Research"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0770","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1526-4610.2011.01843.x","article-title":"5-HT(1D) receptor immunoreactivity in the sphenopalatine ganglion: Implications for the efficacy of triptans in the treatment of autonomic signs associated with cluster headache","volume":"51","author":"Ivanusic","year":"2011","journal-title":"Headache"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0775","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1046\/j.1468-2982.1996.1606412.x","article-title":"Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs","volume":"16","author":"Iversen","year":"1996","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0780","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3959(89)90067-5","article-title":"Intravenous nitroglycerin as an experimental-model of vascular headache - Basic characteristics","volume":"38","author":"Iversen","year":"1989","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0785","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1526-4610.2005.05153.x","article-title":"Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1\/COX2 inhibitors","volume":"45","author":"Jakubowski","year":"2005","journal-title":"Headache"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0790","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.neuroscience.2007.04.064","article-title":"Sensitization of central trigeminovascular neurons: blockade by intravenous naproxen infusion","volume":"148","author":"Jakubowski","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0795","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.npep.2014.01.004","article-title":"PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor","volume":"48","author":"Jansen-Olesen","year":"2014","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0800","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1097\/00001756-199707070-00029","article-title":"5-HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs","volume":"8","author":"Johnson","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0805","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ana.23869","article-title":"Pain referral patterns of the C1 to C3 nerves: Implications for headache disorders","volume":"74","author":"Johnston","year":"2013","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0810","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0024-3205(69)90023-X","article-title":"Mitochondrial alterations in the spinal ganglion cells of the rat accompanying the long-lasting sensory disturbance induced by capsaicin","volume":"8","author":"Joo","year":"1969","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0815","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1468-2982.2005.00836.x","article-title":"Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack","volume":"25","author":"Juhasz","year":"2005","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0820","article-title":"Long-term effectiveness of sphenopalatine ganglion stimulation for cluster headache","author":"Jurgens","year":"2016","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0825","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1177\/0333102414530524","article-title":"Stimulation of the sphenopalatine ganglion in intractable cluster headache: Expert consensus on patient selection and standards of care","volume":"34","author":"Jurgens","year":"2014","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0830","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF01046588","article-title":"Glutamate-immunoreactivity in the trigeminal and dorsal root ganglia, and intraspinal neurons and fibres in the dorsal horn of the rat","volume":"23","author":"Kai-Kai","year":"1991","journal-title":"The Histochemical Journal"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0835","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1126\/science.1231897","article-title":"Spreading depression triggers headache by activating neuronal Panx1 channels","volume":"339","author":"Karatas","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0840","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000117004","article-title":"Anti-migraine compounds fail to modulate the propagation of cortical spreading depression in the cat","volume":"34","author":"Kaube","year":"1994","journal-title":"European Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0845","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1476-5381.1993.tb13643.x","article-title":"Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption","volume":"109","author":"Kaube","year":"1993","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0850","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0006-8993(93)90486-7","article-title":"Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat","volume":"629","author":"Kaube","year":"1993","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0855","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1468-2982.1992.1203133.x","article-title":"Activation of the trigeminovascular system by mechanical distension of the superior sagittal sinus in the cat [see comments]","volume":"12","author":"Kaube","year":"1992","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0860","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1526-4610.2004.04168.x","article-title":"The premonitory symptoms (prodrome): A tertiary care study of 893 migraineurs","volume":"44","author":"Kelman","year":"2004","journal-title":"Headache"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0865","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00213-005-2200-z","article-title":"Ionotropic and metabotropic glutamate receptor structure and pharmacology","volume":"179","author":"Kew","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0870","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1210\/jcem-56-2-269","article-title":"Polyuria and inappropriate secretion of arginine vasopressin in hypothalamic sarcoidosis","volume":"56","author":"Kirkland","year":"1983","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0875","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0306-4522(01)00303-7","article-title":"The periaqueductal gray matter modulates trigeminovascular input: a role in migraine?","volume":"106","author":"Knight","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0880","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0304-3940(02)01250-8","article-title":"Trigeminal antinociception induced by bicuculline in the periaqueductal gray (PAG) is not affected by PAG P\/Q-type calcium channel blockade in rat","volume":"336","author":"Knight","year":"2003","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0885","doi-asserted-by":"crossref","first-page":"RC213","DOI":"10.1523\/JNEUROSCI.22-05-j0002.2002","article-title":"P\/Q-type calcium-channel blockade in the periaqueductal gray facilitates trigeminal nociception: a functional genetic link for migraine?","volume":"22","author":"Knight","year":"2002","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0890","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2005.01.091","article-title":"Patterns of fos expression in the rostral medulla and caudal pons evoked by noxious craniovascular stimulation and periaqueductal gray stimulation in the cat","volume":"1045","author":"Knight","year":"2005","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0895","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00001756-200203250-00030","article-title":"Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia","volume":"13","author":"Knutsson","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0900","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1525-1403.2010.00312.x","article-title":"Central effects of occipital nerve electrical stimulation studied by functional magnetic resonance imaging","volume":"14","author":"Kovacs","year":"2011","journal-title":"Neuromodulation"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0905","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/brain\/81.3.364","article-title":"Corticobular connexions to the pons and lower brain-stem in man: An anatomical study","volume":"81","author":"Kuypers","year":"1958","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0910","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0167-0115(02)00099-X","article-title":"Molecular pharmacology and structure of VPAC Receptors for VIP and PACAP","volume":"108","author":"Laburthe","year":"2002","journal-title":"Regulatory Peptides"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0915","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1136\/jnnp.2008.157743","article-title":"Cranial autonomic symptoms in migraine: characteristics and comparison with cluster headache","volume":"80","author":"Lai","year":"2009","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0920","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/0333102413508239","article-title":"Stimulation of dural vessels excites the SI somatosensory cortex of the cat via a relay in the thalamus","volume":"34","author":"Lambert","year":"2014","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0925","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1468-2982.2008.01572.x","article-title":"Cortico-NRM influences on trigeminal neuronal sensation","volume":"28","author":"Lambert","year":"2008","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0930","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1177\/0333102411422383","article-title":"Effect of cortical spreading depression on basal and evoked traffic in the trigeminovascular sensory system","volume":"31","author":"Lambert","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0935","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/jnnp.2005.063750","article-title":"Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura","volume":"76","author":"Lampl","year":"2005","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0940","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/brain\/awh295","article-title":"Hyperexcitability of the primary somatosensory cortex in migraine--A magnetoencephalographic study","volume":"127","author":"Lang","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0945","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1468-2982.2002.00310.x","article-title":"CGRP may play a causative role in migraine","volume":"22","author":"Lassen","year":"2002","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0950","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/cne.21607","article-title":"Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: Differences between peripheral and central CGRP receptor distribution","volume":"507","author":"Lennerz","year":"2008","journal-title":"The Journal of Comparative Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0955","first-page":"5","article-title":"Results of a randomized, double-blind, placebo controlled, phase 2 study to evaluate the efficacy and safety of AMG 334 for the prevention of episodic migraine","volume":"35","author":"Lenz","year":"2015","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0960","article-title":"Deep brain stimulation in headache","author":"Leone","year":"2015","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0965","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.pain.2007.03.012","article-title":"Mast cell degranulation activates a pain pathway underlying migraine headache","volume":"130","author":"Levy","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0970","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/ana.20619","article-title":"Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: Implications for the pathophysiology of migraine","volume":"58","author":"Levy","year":"2005","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0975","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1073\/pnas.0306147101","article-title":"Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT 1B\/1D receptor agonists","volume":"101","author":"Levy","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0980","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1460-9568.2008.06068.x","article-title":"Sensitization of meningeal nociceptors: Inhibition by naproxen","volume":"27","author":"Levy","year":"2008","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0985","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neulet.2005.12.058","article-title":"After-effects of transcranial direct current stimulation (tDCS) on cortical spreading depression","volume":"398","author":"Liebetanz","year":"2006","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0990","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/ana.21211","article-title":"Cutaneous allodynia in the migraine population","volume":"63","author":"Lipton","year":"2008","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb0995","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","article-title":"Migraine prevalence, disease burden, and the need for preventive therapy","volume":"68","author":"Lipton","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1000","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1474-4422(10)70054-5","article-title":"Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: A randomised, double-blind, parallel-group, sham-controlled trial","volume":"9","author":"Lipton","year":"2010","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1005","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1046\/j.1526-4610.2001.041007646.x","article-title":"Prevalence and burden of migraine in the United States: Data from the American Migraine Study II","volume":"41","author":"Lipton","year":"2001","journal-title":"Headache"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1010","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.neuroscience.2004.07.045","article-title":"Central projections of sensory innervation of the rat superior sagittal sinus","volume":"129","author":"Liu","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.brainres.2008.02.078","article-title":"Central projections of the sensory innervation of the rat middle meningeal artery","volume":"1208","author":"Liu","year":"2008","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1020","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1468-2982.2008.01829.x","article-title":"Brainstem and thalamic projections from a craniovascular sensory nervous centre in the rostral cervical spinal dorsal horn of rats","volume":"29","author":"Liu","year":"2009","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1025","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1046\/j.1468-2982.1997.1708833.x","article-title":"Differential distribution of 5HT1D- and 5HT1B-immunoreactivity within the human trigemino-cerebrovascular system: Implications for the discovery of new antimigraine drugs","volume":"17","author":"Longmore","year":"1997","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1030","first-page":"299","article-title":"Bulbar raphe neurones with projections to the trigeminal nucleus caudalis and the lumbar cord in the rat: A fluorescence double-labelling study","volume":"50","author":"Lovick","year":"1983","journal-title":"Experimental Brain Research"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1035","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0306-4522(83)90303-2","article-title":"Projections from brain stem nuclei to the spinal trigeminal nucleus in the cat","volume":"9","author":"Lovick","year":"1983","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1040","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/00001756-200106130-00015","article-title":"Co-localization of 5-HT(1B\/1D\/1F) receptors and glutamate in trigeminal ganglia in rats","volume":"12","author":"Ma","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1045","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1046\/j.0953-816x.2001.01586.x","article-title":"Colocalization of CGRP with 5-HT1B\/1D receptors and substance P in trigeminal ganglion neurons in rats","volume":"13","author":"Ma","year":"2001","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1050","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/head.12756","article-title":"What have we learned from brain functional connectivity studies in migraine headache?","volume":"56","author":"Maleki","year":"2016","journal-title":"Headache"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1744-8069-7-71","article-title":"Migraine attacks the basal ganglia","volume":"7","author":"Maleki","year":"2011","journal-title":"Molecular Pain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1060","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/(SICI)1096-9861(19981012)400:1<125::AID-CNE9>3.0.CO;2-B","article-title":"Cells of origin of the trigeminohypothalamic tract in the rat","volume":"400","author":"Malick","year":"1998","journal-title":"Journal of Comparative Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1065","doi-asserted-by":"crossref","first-page":"9930","DOI":"10.1073\/pnas.171616898","article-title":"A neurohistochemical blueprint for pain-induced loss of appetite","volume":"98","author":"Malick","year":"2001","journal-title":"Proceedings of the Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1070","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1152\/jn.2000.84.4.2078","article-title":"Trigeminohypothalamic and reticulohypothalamic tract neurons in the upper cervical spinal cord and caudal medulla of the rat","volume":"84","author":"Malick","year":"2000","journal-title":"Journal of Neurophysiology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1075","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/brain\/awt320","article-title":"Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks","volume":"137","author":"Maniyar","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1080","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/cne.902030414","article-title":"The central projections of trigeminal primary afferent neurons in the cat as determined by the tranganglionic transport of horseradish peroxidase","volume":"203","author":"Marfurt","year":"1981","journal-title":"The Journal of Comparative Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1085","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1523\/JNEUROSCI.07-12-04129.1987","article-title":"Neurogenically mediated leakage of plasma proteins occurs from blood vessels in dura mater but not brain","volume":"7","author":"Markowitz","year":"1987","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1090","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.1468-2982.1988.0802083.x","article-title":"Neurogenically mediated plasma extravasation in dura mater: Effect of ergot alkaloids. A possible mechanism of action in vascular headache","volume":"8","author":"Markowitz","year":"1988","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1095","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1468-2982.1993.1302089.x","article-title":"Neuroexcitatory amino acid levels in plasma and cerebrospinal fluid during migraine attacks","volume":"13","author":"Martinez","year":"1993","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1100","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1152\/jn.00249.2005","article-title":"Deconstructing endogenous pain modulations","volume":"94","author":"Mason","year":"2005","journal-title":"Journal of Neurophysiology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1105","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0006-8993(92)90430-H","article-title":"Binding sites for pituitary adenylate cyclase activating polypeptide (PACAP): Comparison with vasoactive intestinal polypeptide (VIP) binding site localization in rat brain sections","volume":"575","author":"Masuo","year":"1992","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1110","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/0306-4522(82)90256-1","article-title":"The cells of origin of the trigeminothalamic, trigeminospinal and trigeminocerebellar projections in the cat","volume":"7","author":"Matsushita","year":"1982","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1115","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00004647-199902000-00001","article-title":"The trigeminovascular system in humans: Pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation","volume":"19","author":"May","year":"1999","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1120","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00004647-199902000-00001","article-title":"The trigeminovascular system in humans: Pathophysiological implications for primary headache syndromes of the neural influences on the cerebral circulation","volume":"19","author":"May","year":"1999","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1125","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0140-6736(98)02470-2","article-title":"Hypothalamic activation in cluster headache attacks","volume":"352","author":"May","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3959(97)00144-9","article-title":"Experimental cranial pain elicited by capsaicin: A PET study","volume":"74","author":"May","year":"1998","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1135","series-title":"Physiological aspects of clinical neurology","first-page":"279","article-title":"Innervation of intracranial structures: A reappraisal","author":"McNaughton","year":"1977"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1140","series-title":"The skin senses","first-page":"423","article-title":"Sensory, motivational, and central control determinants of pain","author":"Melzack","year":"1968"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1145","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0301-0082(02)00009-6","article-title":"Descending control of pain","volume":"66","author":"Millan","year":"2002","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1150","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0014-2999(95)00198-T","article-title":"Autoradiographic mapping of [3H]sumatriptan binding in cat brain stem and spinal cord","volume":"280","author":"Mills","year":"1995","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1155","doi-asserted-by":"crossref","first-page":"7572","DOI":"10.1523\/JNEUROSCI.0193-12.2012","article-title":"Is there a relationship between throbbing pain and arterial pulsations?","volume":"32","author":"Mirza","year":"2012","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1160","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0014-2999(99)00067-9","article-title":"Both 5-HT1B and 5-HT1F receptors modulate c-fos expression within rat trigeminal nucleus caudalis","volume":"369","author":"Mitsikostas","year":"1999","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1165","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1046\/j.1468-2982.2002.00382.x","article-title":"5-Hydroxytryptamine(1B\/1D) and 5-hydroxytryptamine1F receptors inhibit capsaicin-induced c-fos immunoreactivity within mouse trigeminal nucleus caudalis","volume":"22","author":"Mitsikostas","year":"2002","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1170","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.pain.2013.02.013","article-title":"Does throbbing pain have a brain signature?","volume":"154","author":"Mo","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ana.410160202","article-title":"The neurobiology of vascular head pain","volume":"16","author":"Moskowitz","year":"1984","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1180","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0733-8619(18)30318-9","article-title":"Basic mechanisms in vascular headache","volume":"8","author":"Moskowitz","year":"1990","journal-title":"Neurologic Clinics"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1185","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1523\/JNEUROSCI.13-03-01167.1993","article-title":"Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms","volume":"13","author":"Moskowitz","year":"1993","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1190","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990\u20132010: A systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1195","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1177\/0333102410370873","article-title":"Preclinical pharmacological profile of the selective 5-HT1F receptor agonist lasmiditan","volume":"30","author":"Nelson","year":"2010","journal-title":"Cephalalgia"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2016.12.005_bb1200","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.pain.2013.07.021","article-title":"Migraine pathophysiology: Anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain","volume":"154","author":"Noseda","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1205","doi-asserted-by":"crossref","first-page":"14420","DOI":"10.1523\/JNEUROSCI.3025-10.2010","article-title":"Changes of meningeal excitability mediated by corticotrigeminal networks: A link for the endogenous modulation of migraine pain","volume":"30","author":"Noseda","year":"2010","journal-title":"The Journal of Neuroscience: The official journal of the Society for Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1210","doi-asserted-by":"crossref","first-page":"14204","DOI":"10.1523\/JNEUROSCI.3285-11.2011","article-title":"Cortical projections of functionally identified thalamic trigeminovascular neurons: Implications for migraine headache and its associated symptoms","volume":"31","author":"Noseda","year":"2011","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1215","doi-asserted-by":"crossref","first-page":"e103929","DOI":"10.1371\/journal.pone.0103929","article-title":"Neurochemical pathways that converge on thalamic trigeminovascular neurons: Potential substrate for modulation of migraine by sleep, food intake, stress and anxiety","volume":"9","author":"Noseda","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1220","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa030505","article-title":"Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine","volume":"350","author":"Olesen","year":"2004","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1225","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0092-8674(00)81373-2","article-title":"Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4","volume":"87","author":"Ophoff","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1230","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.pain.2014.02.009","article-title":"Noninvasive vagus nerve stimulation as treatment for trigeminal allodynia","volume":"155","author":"Oshinsky","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1235","first-page":"124","article-title":"A randomised, single-blind, placebo-controlled, adaptive clinical trial of GW274150, a selective iNOS inhibitor, in the treatment of acute migraine","volume":"29","author":"Palmer","year":"2009","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1240","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/0748730404269008","article-title":"It's all in the timing: many clocks, many outputs","volume":"19","author":"Panda","year":"2004","journal-title":"Journal of Biological Rhythms"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1245","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0014-2999(95)00748-2","article-title":"[3H]Sumatriptan binding sites in human brain: Regional-dependent labelling of 5-HT1D and 5-HT1F receptors","volume":"295","author":"Pascual","year":"1996","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1250","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archneurpsyc.1940.02280070051003","article-title":"Dural headache and the innervation of the dura mater","volume":"44","author":"Penfield","year":"1940","journal-title":"Archives of Neurology and Psychiatry"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1255","series-title":"The human nervous system","article-title":"Thalamus","author":"Percheron","year":"2003"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1260","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/sj.bjp.0705966","article-title":"Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the rat","volume":"143","author":"Petersen","year":"2004","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1265","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1468-2982.2004.00830.x","article-title":"The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers","volume":"25","author":"Petersen","year":"2005","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1270","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/S0024-3205(97)00885-0","article-title":"Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: Binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine","volume":"61","author":"Phebus","year":"1997","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1275","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1468-2982.2007.01497.x","article-title":"Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine","volume":"28","author":"Rahmann","year":"2008","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1280","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1526-4610.1987.hed2708416.x","article-title":"Headache may arise from perturbation of brain","volume":"27","author":"Raskin","year":"1987","journal-title":"Headache"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1285","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1046\/j.1468-2982.1992.1204221.x","article-title":"Migraine with aura and migraine without aura: An epidemiological study","volume":"12","author":"Rasmussen","year":"1992","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1290","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archsurg.1940.01210040002001","article-title":"Experimental studies on headache. Pain sensitive structures of the head and their significance in headache","volume":"41","author":"Ray","year":"1940","journal-title":"Archives of Surgery"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1295","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2125.1999.00851.x","article-title":"Vasoconstriction in human isolated middle meningeal arteries: Determining the contribution of 5-HT1B- and 5-HT1F-receptor activation","volume":"47","author":"Razzaque","year":"1999","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1300","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1046\/j.1468-2982.2000.00022.x","article-title":"SB-220453, a potential novel antimigraine agent, inhibits nitric oxide release following induction of cortical spreading depression in the anaesthetized cat","volume":"20","author":"Read","year":"2000","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1305","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1093\/brain\/124.12.2490","article-title":"Delayed inflammation in rat meninges: Implications for migraine pathophysiology","volume":"124","author":"Reuter","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1310","doi-asserted-by":"crossref","first-page":"8827","DOI":"10.1523\/JNEUROSCI.0439-13.2013","article-title":"Paraventricular hypothalamic regulation of trigeminovascular mechanisms involved in headaches","volume":"33","author":"Robert","year":"2013","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1315","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jns.2014.12.018","article-title":"Transcranial direct current stimulation in the prophylactic treatment of migraine based on interictal visual cortex excitability abnormalities: A pilot randomized controlled trial","volume":"349","author":"Rocha","year":"2015","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1320","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/1531-8249(200002)47:2<238::AID-ANA15>3.0.CO;2-L","article-title":"No acute antimigraine efficacy of CP-122,288, a highly potent inhibitor of neurogenic inflammation: Results of two randomized, double-blind, placebo-controlled clinical trials","volume":"47","author":"Roon","year":"2000","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1325","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1146\/annurev-pharmtox-010814-124701","article-title":"Calcitonin gene-related peptide (CGRP): A new target for migraine","volume":"55","author":"Russo","year":"2015","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1330","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1046\/j.1468-2982.2002.00387.x","article-title":"Vagal nerve stimulation aborts migraine in patient with intractable epilepsy","volume":"22","author":"Sadler","year":"2002","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1335","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrn2092","article-title":"The neural circuit of orexin (hypocretin): Maintaining sleep and wakefulness","volume":"8","author":"Sakurai","year":"2007","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1340","doi-asserted-by":"crossref","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1345","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2016.0653","article-title":"The \u201cpain matrix\u201d in pain-free individuals","author":"Salomons","year":"2016","journal-title":"JAMA Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1350","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/nature04284","article-title":"Hypothalamic regulation of sleep and circadian rhythms","volume":"437","author":"Saper","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1355","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1212\/01.wnl.0000479686.32453.cc","article-title":"Migraine prevention with a supraorbital transcutaneous stimulator: A randomized controlled trial","volume":"86","author":"Schoenen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1360","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1177\/0333102412473667","article-title":"Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: A randomized, sham-controlled study","volume":"33","author":"Schoenen","year":"2013","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1365","doi-asserted-by":"crossref","DOI":"10.1177\/0333102416636022","article-title":"Noninvasive neurostimulation methods for migraine therapy: The available evidence","author":"Schoenen","year":"2016","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1370","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1093\/brain\/awn094","article-title":"Migraine headache is not associated with cerebral or meningeal vasodilatation--A 3T magnetic resonance angiography study","volume":"131","author":"Schoonman","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1375","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1093\/brain\/aww097","article-title":"The migraine generator revisited: Continuous scanning of the migraine cycle over 30 days and three spontaneous attacks","volume":"139","author":"Schulte","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1380","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/brain\/awn307","article-title":"PACAP38 induces migraine-like attacks in patients with migraine without aura","volume":"132","author":"Schytz","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1385","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/jnnp.23.1.23","article-title":"Observations on 500 cases of migraine and allied vascular headache","volume":"23","author":"Selby","year":"1960","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1390","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1891\/0730-0832.19.6.9","article-title":"The hypothalamus","volume":"19","author":"Settle","year":"2000","journal-title":"Neonatal Network"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1395","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/brain\/awh298","article-title":"Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: A role in migraine?","volume":"128","author":"Shields","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1400","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.nbd.2006.04.003","article-title":"Serotonin receptors modulate trigeminovascular responses in ventroposteromedial nucleus of thalamus: a migraine target?","volume":"23","author":"Shields","year":"2006","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1405","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0006-8993(83)90928-9","article-title":"The cells of origin of cat trigeminothalamic projections: Especially in the caudal medulla","volume":"277","author":"Shigenaga","year":"1983","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1410","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1212\/WNL.0000000000002918","article-title":"Chronic migraine headache prevention with noninvasive vagus nerve stimulation: The EVENT study","volume":"87","author":"Silberstein","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1415","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0333102412462642","article-title":"Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: results from a randomized, multicenter, double-blinded, controlled study","volume":"32","author":"Silberstein","year":"2012","journal-title":"Cephalalgia"},{"issue":"Suppl. 2","key":"10.1016\/j.pharmthera.2016.12.005_bb1420","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1468-2982.2009.01974.x","article-title":"Tonabersat, a gap-junction modulator: efficacy and safety in two randomized, placebo-controlled, dose-ranging studies of acute migraine","volume":"29","author":"Silberstein","year":"2009","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1425","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/088307380401900507","article-title":"Molecular biology and ontogeny of glutamate receptors in the mammalian central nervous system","volume":"19","author":"Simeone","year":"2004","journal-title":"Journal of Child Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1430","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1046\/j.1468-2982.2000.00092.x","article-title":"Repetitive cortical spreading depression in a gyrencephalic feline brain: Inhibition by the novel benzoylamino-benzopyran SB-220453","volume":"20","author":"Smith","year":"2000","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1435","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-0270(97)00209-4","article-title":"Development and characterisation of human 5-HT1B- or 5-HT1D-receptor specific antibodies as unique research tools","volume":"80","author":"Smith","year":"1998","journal-title":"Journal of Neuroscience Methods"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1440","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0006-8993(90)90125-U","article-title":"CNS projections to the pterygopalatine parasympathetic preganglionic neurons in the rat: a retrograde transneuronal viral cell body labeling study","volume":"534","author":"Spencer","year":"1990","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1445","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1523\/JNEUROSCI.4496-10.2011","article-title":"Trigeminal nociceptive transmission in migraineurs predicts migraine attacks","volume":"31","author":"Stankewitz","year":"2011","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1450","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1468-2982.1997.1702109.x","article-title":"Lamotrigine versus placebo in the prophylaxis of migraine with and without aura","volume":"17","author":"Steiner","year":"1997","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1455","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/01.jom.0000099999.27348.78","article-title":"Lost productive work time costs from health conditions in the United States: results from the American Productivity Audit","volume":"45","author":"Stewart","year":"2003","journal-title":"Journal of Occupational and Environmental Medicine"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1460","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/120.12.2171","article-title":"Microiontophoretic application of serotonin (5HT)1B\/1D agonists inhibits trigeminal cell firing in the cat","volume":"120","author":"Storer","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1465","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/j.1468-2982.2004.00767.x","article-title":"Topiramate inhibits trigeminovascular neurons in the cat","volume":"24","author":"Storer","year":"2004","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1470","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/sj.bjp.0705807","article-title":"Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat","volume":"142","author":"Storer","year":"2004","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1475","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/384560a0","article-title":"Sensitization of meningeal sensory neurons and the origin of headaches","volume":"384","author":"Strassman","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1480","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1186\/s10194-015-0543-3","article-title":"Treatment of chronic migraine with transcutaneous stimulation of the auricular branch of the vagal nerve (auricular t-VNS): A randomized, monocentric clinical trial","volume":"16","author":"Straube","year":"2015","journal-title":"The Journal of Headache and Pain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1485","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1093\/brain\/awq224","article-title":"Modulation of nocioceptive transmission with calcitonin gene-related peptide receptor antagonists in the thalamus","volume":"133","author":"Summ","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1490","first-page":"903","article-title":"GABAA receptors in the nucleus raphe magnus modulate trigeminal cell firing responsive to activation of craniovascular and dural afferents","volume":"52","author":"Supronsinchai","year":"2012","journal-title":"Headache"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1495","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/jcbfm.1988.117","article-title":"Origins and pathways of cerebrovascular vasoactive intestinal polypeptide-positive nerves in rat","volume":"8","author":"Suzuki","year":"1988","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1500","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1046\/j.1468-2982.2001.00140.x","article-title":"Neuropeptide localization in the \u201cmigraine generator\u201d region of the human brainstem","volume":"21","author":"Tajti","year":"2001","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1505","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0165-1838(99)00024-7","article-title":"Messenger molecules and receptor mRNA in the human trigeminal ganglion","volume":"76","author":"Tajti","year":"1999","journal-title":"Journal of the Autonomic Nervous System"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1510","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1526-4610.2009.01451.x","article-title":"Acute treatment of intractable migraine with sphenopalatine ganglion electrical stimulation","volume":"49","author":"Tepper","year":"2009","journal-title":"Headache"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1515","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2165\/00003495-200060060-00003","article-title":"Triptans in migraine: A comparative review of pharmacology, pharmacokinetics and efficacy","volume":"60","author":"Tfelt-Hansen","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1520","doi-asserted-by":"crossref","first-page":"18985","DOI":"10.1073\/pnas.1215435109","article-title":"Critical role of calcitonin gene-related peptide receptors in cortical spreading depression","volume":"109","author":"Tozzi","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1525","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1507\/endocrj.EJ12-0030","article-title":"Role of orexin in the central regulation of glucose and energy homeostasis","volume":"59","author":"Tsuneki","year":"2012","journal-title":"Endocrine Journal"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1530","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.peptides.2011.12.019","article-title":"Peripheral and central alterations of pituitary adenylate cyclase activating polypeptide-like immunoreactivity in the rat in response to activation of the trigeminovascular system","volume":"33","author":"Tuka","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1535","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1177\/0333102413483931","article-title":"Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients","volume":"33","author":"Tuka","year":"2013","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1540","first-page":"230","article-title":"Neuropeptides in the cerebral circulation","volume":"1","author":"Uddman","year":"1989","journal-title":"Cerebrovascular and Brain Metabolism Reviews"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1545","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0304-3940(85)90296-4","article-title":"Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: Trigeminal origin and co-existence with substance P","volume":"62","author":"Uddman","year":"1985","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1550","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/jcbfm.1993.36","article-title":"PACAP, a VIP-like peptide, immunohistochemical localization and effect upon cat pial arteries and cerebral blood flow","volume":"13","author":"Uddman","year":"1993","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1555","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1046\/j.1468-2982.2002.00324.x","article-title":"Neuropeptide expression in the human trigeminal nucleus caudalis and in the cervical spinal cord C1 and C2","volume":"22","author":"Uddman","year":"2002","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1560","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0896-6273(04)00085-6","article-title":"A Cacna1a knock-in migraine mouse model with increased susceptibility to cortical spreading depression","volume":"41","author":"van den Maagdenberg","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1565","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/(SICI)1096-9861(20000501)420:2<233::AID-CNE6>3.0.CO;2-T","article-title":"Thalamic projections from the whisker-sensitive regions of the spinal trigeminal complex in the rat","volume":"420","author":"Veinante","year":"2000","journal-title":"The Journal of Comparative Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1570","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1129-2377-14-23","article-title":"Transcranial Direct Current Stimulation (tDCS) of the visual cortex: A proof-of-concept study based on interictal electrophysiological abnormalities in migraine","volume":"14","author":"Vigano","year":"2013","journal-title":"The Journal of Headache and Pain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1575","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF00168556","article-title":"[3H]sumatriptan labels both 5-HT1D and 5-HT1F receptor binding sites in the guinea pig brain: An autoradiographic study","volume":"352","author":"Waeber","year":"1995","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1580","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/acn3.302","article-title":"Metabotropic glutamate receptor 5: A target for migraine therapy","volume":"3","author":"Waung","year":"2016","journal-title":"Annals of Clinical Translational Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1585","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nm0795-658","article-title":"Brain stem activation in spontaneous human migraine attacks","volume":"1","author":"Weiller","year":"1995","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1590","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1468-2982.2009.01923.x","article-title":"Prostaglandin I2 (epoprostenol) triggers migraine-like attacks in migraineurs","volume":"30","author":"Wienecke","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1595","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1460-9568.1994.tb00286.x","article-title":"Differential foci and synaptic organization of the principal and spinal trigeminal projections to the thalamus in the rat","volume":"6","author":"Williams","year":"1994","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1600","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1468-2982.1997.1704525.x","article-title":"Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetized rat--Intravital microscope studies","volume":"17","author":"Williamson","year":"1997","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1605","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0014-2999(97)83028-2","article-title":"The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation","volume":"328","author":"Williamson","year":"1997","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1610","series-title":"Headache and other head pain","author":"Wolff","year":"1963"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1615","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1744-8069-4-12","article-title":"Release of glutamate and CGRP from trigeminal ganglion neurons: Role of calcium channels and 5-HT1 receptor signaling","volume":"4","author":"Xiao","year":"2008","journal-title":"Molecular Pain"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1620","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/BF02423504","article-title":"Stimulation of cranial vessels excites nociceptive neurones in several thalamic nuclei of the cat","volume":"81","author":"Zagami","year":"1990","journal-title":"Experimental Brain Research"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1625","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0304-3940(91)90681-I","article-title":"Craniovascular application of capsaicin activates nociceptive thalamic neurones in the cat","volume":"121","author":"Zagami","year":"1991","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1630","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/acn3.113","article-title":"Pituitary adenylate cyclase activating polypeptide and migraine","volume":"1","author":"Zagami","year":"2014","journal-title":"Annals of Clinical Translational Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1635","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/ana.23873","article-title":"Vascular extracellular signal-regulated kinase mediates migraine-related sensitization of meningeal nociceptors","volume":"73","author":"Zhang","year":"2013","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1640","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/ana.22329","article-title":"Activation of central trigeminovascular neurons by cortical spreading depression","volume":"69","author":"Zhang","year":"2011","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1645","doi-asserted-by":"crossref","first-page":"8807","DOI":"10.1523\/JNEUROSCI.0511-10.2010","article-title":"Activation of meningeal nociceptors by cortical spreading depression: Implications for migraine with aura","volume":"30","author":"Zhang","year":"2010","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.12.005_bb1650","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1124\/jpet.107.123745","article-title":"Sensitization and activation of intracranial meningeal nociceptors by mast cell mediators","volume":"322","author":"Zhang","year":"2007","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725816302480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725816302480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T21:50:27Z","timestamp":1749765027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725816302480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":330,"alternative-id":["S0163725816302480"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2016.12.005","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current and novel insights into the neurophysiology of migraine and its implications for therapeutics","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2016.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}